Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Seung Hee | - |
dc.contributor.author | Cho, Hee-Jeong | - |
dc.contributor.author | Shim, Gayong | - |
dc.contributor.author | Lee, Sangbin | - |
dc.contributor.author | Kim, Su-Hyeon | - |
dc.contributor.author | Choi, Han-Gon | - |
dc.contributor.author | Kim, Chan-Wha | - |
dc.contributor.author | Oh, Yu-Kyoung | - |
dc.date.accessioned | 2021-06-23T10:04:07Z | - |
dc.date.available | 2021-06-23T10:04:07Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2011-12 | - |
dc.identifier.issn | 0724-8741 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/36362 | - |
dc.description.abstract | To test whether co-delivery of anticancer small interfering RNA (siRNA) and a chemical MEK inhibitor using cationic liposomes enhances anticancer activity in vitro and in vivo. MEK inhibitor PD0325901 was encapsulated in lipid layers of N',N''-dioleylglutamide-based cationic liposomes (DGL). Mcl1-specific siRNA (siMcl1) was complexed to DGL or PD0325901-loaded liposomes (PDGL). Efficiency of cellular siRNA delivery was tested using fluorescent double-stranded RNA. Silencing of target proteins was evaluated using Western blotting and real-time quantitative polymerase chain reactions. In vivo anticancer activity was tested using xenografted mice. Size and zeta potential of PDGL were similar to DGL. PDGL could deliver double-stranded RNA into cells with efficiencies comparable to DGL. Cellular co-delivery of siMcl1 and PD0325901 reduced expression of Mcl1 and pERK1/2 proteins and more effectively reduced tumor cell survival than other treatments. In mice, siMcl1 and PD0325901 co-delivered by PDGL inhibited growth of tumors 79%. Substantial apoptosis of tumor cells was observed following PDGL-mediated co-delivery of siMcl1, but not in other groups. PDGL-mediated co-delivery of siMcl1 and MEK inhibitor, PD0325901, could serve as a potential strategy for combination chemogene anticancer therapy. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER/PLENUM PUBLISHERS | - |
dc.title | Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Han-Gon | - |
dc.identifier.doi | 10.1007/s11095-011-0569-4 | - |
dc.identifier.scopusid | 2-s2.0-83555173191 | - |
dc.identifier.wosid | 000297710200010 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICAL RESEARCH, v.28, no.12, pp.3069 - 3078 | - |
dc.relation.isPartOf | PHARMACEUTICAL RESEARCH | - |
dc.citation.title | PHARMACEUTICAL RESEARCH | - |
dc.citation.volume | 28 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 3069 | - |
dc.citation.endPage | 3078 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CELL LUNG-CANCER | - |
dc.subject.keywordPlus | MESOPOROUS SILICA NANOPARTICLES | - |
dc.subject.keywordPlus | OVERCOME DRUG-RESISTANCE | - |
dc.subject.keywordPlus | CARCINOMA CELLS | - |
dc.subject.keywordPlus | PHASE-II | - |
dc.subject.keywordPlus | SIRNA | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | PD0325901 | - |
dc.subject.keywordPlus | MCL-1 | - |
dc.subject.keywordAuthor | co-delivery | - |
dc.subject.keywordAuthor | combination therapy | - |
dc.subject.keywordAuthor | liposome | - |
dc.subject.keywordAuthor | MEK inhibitor | - |
dc.subject.keywordAuthor | siRNA | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs11095-011-0569-4 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.